News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
266,703 Results
Type
Article (13809)
Company Profile (105)
Press Release (252789)
Section
Business (88470)
Career Advice (471)
Deals (15403)
Drug Delivery (67)
Drug Development (36639)
Employer Resources (49)
FDA (6305)
Job Trends (6303)
News (150826)
Policy (14070)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Standard (1)
Academia (450)
Adcomms (6)
Allergies (32)
Alliances (23293)
ALS (36)
Alzheimer's disease (390)
Antibody-drug conjugate (ADC) (36)
Approvals (6342)
Artificial intelligence (102)
Autoimmune disease (8)
Automation (3)
Bankruptcy (149)
Best Places to Work (4452)
BIOSECURE Act (9)
Biosimilars (55)
Biotechnology (44)
Bladder cancer (19)
Brain cancer (15)
Breast cancer (74)
Cancer (588)
Cardiovascular disease (70)
Career advice (412)
Career pathing (11)
CAR-T (20)
Cell therapy (85)
Cervical cancer (4)
Clinical research (30909)
Collaboration (324)
Compensation (134)
Complete response letters (17)
COVID-19 (757)
CRISPR (19)
C-suite (117)
Cystic fibrosis (35)
Data (605)
Denatured (18)
Depression (9)
Diabetes (77)
Diagnostics (1437)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (55)
Drug pricing (63)
Drug shortages (12)
Duchenne muscular dystrophy (33)
Earnings (32161)
Editorial (11)
Employer branding (4)
Employer resources (43)
Events (37714)
Executive appointments (358)
FDA (6699)
Featured Employer (20)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (204)
Gene editing (37)
Generative AI (8)
Gene therapy (100)
GLP-1 (339)
Government (1290)
Grass and pollen (2)
Guidances (15)
Healthcare (3656)
Huntington's disease (4)
IgA nephropathy (10)
Immunology and inflammation (34)
Indications (12)
Infectious disease (790)
Inflammatory bowel disease (54)
Inflation Reduction Act (6)
Influenza (13)
Intellectual property (45)
Interviews (59)
IPO (5898)
IRA (29)
Job creations (2074)
Job search strategy (378)
Kidney cancer (6)
Labor market (10)
Layoffs (178)
Leadership (3)
Legal (3443)
Liver cancer (19)
Lung cancer (79)
Lymphoma (53)
Machine learning (1)
Management (16)
Manufacturing (142)
MASH (31)
Medical device (1299)
Medtech (1301)
Mergers & acquisitions (9693)
Metabolic disorders (246)
Multiple sclerosis (19)
NASH (14)
Neurodegenerative disease (22)
Neuropsychiatric disorders (6)
Neuroscience (560)
NextGen: Class of 2025 (1620)
Non-profit (620)
Northern California (676)
Now hiring (7)
Obesity (140)
Opinion (118)
Ovarian cancer (21)
Pain (50)
Pancreatic cancer (13)
Parkinson's disease (43)
Partnered (7)
Patents (104)
Patient recruitment (28)
Peanut (10)
People (29049)
Pharmaceutical (64)
Pharmacy benefit managers (11)
Phase I (8045)
Phase II (13080)
Phase III (11731)
Pipeline (408)
Podcasts (49)
Policy (59)
Postmarket research (1403)
Preclinical (3213)
Press Release (25)
Prostate cancer (44)
Psychedelics (8)
Radiopharmaceuticals (120)
Rare diseases (158)
Real estate (2675)
Recruiting (17)
Regulatory (10112)
Reports (14)
Research institute (566)
Resumes & cover letters (56)
Rett syndrome (1)
RNA editing (2)
RSV (7)
Schizophrenia (35)
Series A (35)
Series B (11)
Service/supplier (3)
Sickle cell disease (31)
Southern California (692)
Special edition (6)
Spinal muscular atrophy (77)
Sponsored (6)
Startups (1642)
State (2)
Stomach cancer (3)
Supply chain (28)
The Weekly (29)
United States (6909)
Vaccines (150)
Venture capitalists (13)
Webinars (10)
Weight loss (95)
Women's health (8)
Worklife (3)
Date
Today (53)
Last 7 days (270)
Last 30 days (990)
Last 365 days (12141)
2025 (3047)
2024 (12590)
2023 (14332)
2022 (19673)
2021 (20194)
2020 (19162)
2019 (15077)
2018 (11857)
2017 (13936)
2016 (13178)
2015 (15534)
2014 (12478)
2013 (10650)
2012 (11463)
2011 (11968)
2010 (10930)
Location
Africa (313)
Alabama (13)
Alaska (1)
Arizona (56)
Arkansas (4)
Asia (20102)
Australia (2612)
California (1637)
Canada (873)
China (230)
Colorado (66)
Connecticut (66)
Delaware (53)
Europe (39424)
Florida (306)
Georgia (36)
Idaho (9)
Illinois (185)
India (14)
Indiana (128)
Iowa (1)
Japan (86)
Kansas (56)
Kentucky (12)
Maine (2)
Maryland (246)
Massachusetts (1417)
Michigan (28)
Minnesota (89)
Missouri (24)
Montana (8)
Nebraska (6)
Nevada (7)
New Hampshire (6)
New Jersey (721)
New Mexico (7)
New York (482)
North Carolina (382)
North Dakota (2)
Northern California (676)
Ohio (48)
Oklahoma (4)
Oregon (16)
Pennsylvania (412)
Puerto Rico (8)
Rhode Island (7)
South America (504)
South Carolina (2)
Southern California (692)
Tennessee (34)
Texas (250)
Utah (33)
Virginia (70)
Washington D.C. (29)
Washington State (111)
Wisconsin (14)
266,703 Results for "castle creek pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ligand Leads $75 Million Royalty Financing in Castle Creek Biosciences
February 26, 2025
·
6 min read
Business
Silver Creek Pharmaceuticals Appoints Mark Corrigan, M.D. As President
Silver Creek Pharmaceuticals, a clinical-stage biotechnology company focused on the selective targeting of naturally-occurring growth factors to promote cell survival and growth, has appointed Mark Corrigan, MD, as President.
February 12, 2024
·
3 min read
Press Releases
Castle Biosciences to Participate in Upcoming March 2025 Investor Conferences
February 26, 2025
·
1 min read
Kapoose Creek Bio announces advancement of potent compounds in neurology using AI-powered technology
Kapoose Creek Bio, a Vancouver-based biotechnology company leveraging AI for drug discovery from nature, announced the identification and advancement of two lead compounds with exciting potential in neurology, spanning indications in neurodegeneration and mental health.
May 30, 2024
·
3 min read
Press Releases
Castle Biosciences Reports Fourth Quarter and Full-Year 2024 Results
February 27, 2025
·
19 min read
Press Releases
Castle Biosciences to Present New Data at EADO Supporting the Clinical Value of the DecisionDx®-Melanoma Test in Guiding Risk-Aligned Management of Patients with Melanoma
April 1, 2025
·
7 min read
Press Releases
Kapoose Creek Bio Acquires Exclusive License to Adapsyn Bioscience’s World-Leading AI Technology for Drug Development
October 30, 2024
·
3 min read
BioMidwest
Mill Creek’s Frontier Dermatology Is First in Washington to Offer Nonsurgical Treatment for Common Skin Cancer Using Image-Guided Superficial Radiation Therapy
SkinCure Oncology, the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy, a nonsurgical treatment with the highest cure rate for common skin cancers, announced its availability in Washington at an event at Frontier Dermatology in Mill Creek.
April 17, 2024
·
3 min read
Business
Castle Biosciences Announces Updates to its Board of Directors
Castle Biosciences, Inc. announced that Rodney Cotton has been appointed to its board of directors, effective immediately, and will stand for election at Castle’s 2024 Annual Meeting of Stockholders, expected to be held in May 2024.
March 27, 2024
·
3 min read
Press Releases
Castle Biosciences’ DecisionDx®-SCC Data Earns Top Five Abstract at NCCN 2025, Shows Significantly Enhanced Risk Stratification Beyond Current Staging Within NCCN Risk Groups
March 31, 2025
·
8 min read
1 of 26,671
Next
